Taysha Gene Therapies Total Long-Term Assets 2020-2025 | TSHA

Taysha Gene Therapies total long-term assets from 2020 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current

Taysha Gene Therapies Total Long-Term Assets 2020-2025 | TSHA

Taysha Gene Therapies total long-term assets from 2020 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$15.5B
Dr Reddy's Laboratories (RDY)$11.4B
BridgeBio Pharma (BBIO)$6.4B
Bausch Health Cos (BHC)$1.9B
Supernus Pharmaceuticals (SUPN)$1.7B
Amphastar Pharmaceuticals (AMPH)$1.1B
Personalis (PSNL)$282M
Assembly Biosciences (ASMB)$75M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$3M
Teligent (TLGT)$0M